Research ArticleImmunotherapy

Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

See allHide authors and affiliations

Science Translational Medicine  02 Mar 2016:
Vol. 8, Issue 328, pp. 328ra27
DOI: 10.1126/scitranslmed.aae0105

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article